Today’s Top Three in Pharma 022709 posted on February 27, 2009Prasugrel - the saga continues. Gets approval to launch in the EU; positive study results versus Plavix for a certain group of patients; but controversy swirls around FDA approval process. Synta's …Continue Reading about Today’s Top Three in Pharma 022709 →